Skip to main content

Table 4 THE SHARE OF p16INK4a-NEGATIVE SAMPLES AMONG CERVICAL CARCINOMAS (LITERATURE DATA)

From: Protein p16 as a marker of dysplastic and neoplastic alterations in cervical epithelial cells

Research group (reference) The share (per cent) of p16INK4a-negative samples
  among adenocarcinomas:
Lu et al, 1998 (7) 17/40 (42.5%)
Sano et al, 1998 (8) 4/15 (26.7%)
Milde-Langosch et al, 2001(10) 8/58 (13,8%)
Klaes et al, 2001(9) 1/7 (14.3%)
Saqi et al, 2002 (13) 0/2 (0%)
Murphy et al, 2003 (14) 0/2 (0%)
Negri et al, 2003 (15) 0/18 (0%)
Agoff et al, 2003 (16) 2/7 (28.6 %)
Present study 0/5 (0%)
  among squamous cell carcinomas:
Wong et al, 1997 (6) 8/79 (10.1%)
Sano et al, 1998 (8) 1/39 (2.8%)
Klaes et al, 2001 (9) 1/53 (1.9%)
Sano et al, 2002 (12) 0/34 (0%)
Klaes et al, 2002 (4) 0/46 (0%)
Saqi et al, 2002 (13) 0/1 (0 %)
Murphy et al, 2003 (14) 0/8 (0%)
Agoff et al, 2003 (16) 4/46 (8.7%)
Present study 1/21 (4.8%)